Clinical Trial Update: Efficacy of a Novel CCH Protocol for PD Among Prior Non-responders [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update suggests efficacy of a novel collagenase clostridium histolyticum protocol for Peyronie's disease in patients who previously did n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peyronie Disease

Drugs mentioned

• collagenase clostridium histolyticum (collagenase clostridium histolyticum)

Snippet

Sponsor: Charitable Union for the Research and Education of Peyronie's Disease | Conditions: Peyronie's Disease | Phase 4 | Status: ACTIVE_NOT_RECRUITING